Addition of Obinutuzumab to Ibrutinib Enhances Depletion of CLL Cells in the Peripheral Blood and Bone Marrow after 1 Month of Combination Therapy: Initial Results from the Bloodwise TAP Iciclle Extension Study
Andy C Rawstron, Talha Munir, Samuel Munoz Vicente, Kristian Brock, Francesca Yates, Rebecca Bishop, Surita Dalal, Ruth M de Tute, Adrian Bloor, Oonagh M Sheehy, Andrew R Pettitt, Christopher Fox, Christopher Fegan, Stephen Devereux, Donald MacDonald, Peter Hillmen
Research output: Contribution to journal › Abstract › peer-review
Fingerprint
Dive into the research topics of 'Addition of Obinutuzumab to Ibrutinib Enhances Depletion of CLL Cells in the Peripheral Blood and Bone Marrow after 1 Month of Combination Therapy: Initial Results from the Bloodwise TAP Iciclle Extension Study'. Together they form a unique fingerprint.